共 33 条
[33]
Lower risk of hospitalization for heart failure, kidney disease and death with sodium-glucose co-transporter-2 inhibitors compared with dipeptidyl peptidase-4 inhibitors in type 2 diabetes regardless of prior cardiovascular or kidney disease: A retrospective cohort study in UK primary care
[J].
DIABETES OBESITY & METABOLISM,
2021, 23 (10)
:2207-2214